Delivery Order SPE2DR25D3201-SPE2DR26FT4KR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,004.52 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials. This competitively awarded, firm fixed-price contract was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations, with a ceiling value of $8,761.83. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9 billion through December 2026. The award was made through competitive procedures with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,621.17 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities. This competitively awarded, firm fixed-price delivery order is set to be completed by August 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $17,890.25 delivery order to AmerisourceBergen Drug Corp for supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulations. This competitively awarded, firm fixed-price delivery order is set to be completed by November 14, 2025, and represents fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $11,296.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with an ultimate completion date of October 16, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL) with a ceiling value of $14,093.39. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The delivery will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $20,171.71 delivery order to AmerisourceBergen Drug Corp for Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL format, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with a ceiling value of $1,566.65. This is a firm fixed-price delivery order with no set-aside designation, placed under competitive award procedures. The contract is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $11,305.84 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml format, with completion scheduled for November 21, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $19,789.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL format. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside competitive award and is issued under AmerisourceBergen's larger...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4KRDelivery Order
The Defense Logistics Agency awarded a $26,158.82 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL vials, with performance completion targeted for December 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceuticals and medical commodities to support military and veteran healthcare systems. The parent IDC vehicle enables the company to deliver pharmaceutical products across multiple therapeutic domains to customers including the Defense Health Agency and the U.S. Coast Guard. This specific delivery order for Ozempic, a diabetes medication, exemplifies the company's role in fulfilling ongoing pharmaceutical supply requirements within the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.2k | 12/2/25 |